Zai Lab Net Asset
| ZLAB Stock | USD 20.03 1.26 6.71% |
As of the 16th of February 2026, Zai Lab maintains the Market Risk Adjusted Performance of (0.18), mean deviation of 1.99, and Standard Deviation of 2.63. Relative to fundamental indicators, the technical analysis model lets you check existing technical drivers of Zai Lab, as well as the relationship between them.
Zai Lab Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization | Enterprise Value Revenue 3.9341 | Revenue |
Zai | Net Asset | Build AI portfolio with Zai Stock |
Zai Net Asset Driver Correlations
Understanding the fundamental principles of building solid financial models for Zai Lab is extremely important. It helps to project a fair market value of Zai Stock properly, considering its historical fundamentals such as Net Asset. Since Zai Lab's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Zai Lab's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Zai Lab's interrelated accounts and indicators.
Click cells to compare fundamentals
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zai Lab. Anticipated expansion of Zai directly elevates investor willingness to pay premium valuations. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Zai Lab assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share (1.90) | Revenue Per Share | Quarterly Revenue Growth 0.135 | Return On Assets | Return On Equity |
The market value of Zai Lab is measured differently than its book value, which is the value of Zai that is recorded on the company's balance sheet. Investors also form their own opinion of Zai Lab's value that differs from its market value or its book value, called intrinsic value, which is Zai Lab's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Zai Lab's market value can be influenced by many factors that don't directly affect Zai Lab's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Zai Lab's value and its price as these two are different measures arrived at by different means. Investors typically determine if Zai Lab is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, Zai Lab's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Zai Lab 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Zai Lab's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Zai Lab.
| 11/18/2025 |
| 02/16/2026 |
If you would invest 0.00 in Zai Lab on November 18, 2025 and sell it all today you would earn a total of 0.00 from holding Zai Lab or generate 0.0% return on investment in Zai Lab over 90 days. Zai Lab is related to or competes with Legend Biotech, Disc Medicine, Ascentage Pharma, Scholar Rock, Ideaya Biosciences, Centessa Pharmaceuticals, and Xenon Pharmaceuticals. Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and ... More
Zai Lab Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Zai Lab's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Zai Lab upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.06) | |||
| Maximum Drawdown | 10.32 | |||
| Value At Risk | (3.76) | |||
| Potential Upside | 6.01 |
Zai Lab Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Zai Lab's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Zai Lab's standard deviation. In reality, there are many statistical measures that can use Zai Lab historical prices to predict the future Zai Lab's volatility.| Risk Adjusted Performance | (0.02) | |||
| Jensen Alpha | (0.15) | |||
| Total Risk Alpha | (0.31) | |||
| Treynor Ratio | (0.19) |
Zai Lab February 16, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.02) | |||
| Market Risk Adjusted Performance | (0.18) | |||
| Mean Deviation | 1.99 | |||
| Coefficient Of Variation | (2,613) | |||
| Standard Deviation | 2.63 | |||
| Variance | 6.94 | |||
| Information Ratio | (0.06) | |||
| Jensen Alpha | (0.15) | |||
| Total Risk Alpha | (0.31) | |||
| Treynor Ratio | (0.19) | |||
| Maximum Drawdown | 10.32 | |||
| Value At Risk | (3.76) | |||
| Potential Upside | 6.01 | |||
| Skewness | 0.9836 | |||
| Kurtosis | 0.4799 |
Zai Lab Backtested Returns
Zai Lab shows Sharpe Ratio of close to zero, which attests that the company had a close to zero % return per unit of risk over the last 3 months. Zai Lab exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Zai Lab's Standard Deviation of 2.63, mean deviation of 1.99, and Market Risk Adjusted Performance of (0.18) to validate the risk estimate we provide. The firm maintains a market beta of 0.59, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, Zai Lab's returns are expected to increase less than the market. However, during the bear market, the loss of holding Zai Lab is expected to be smaller as well. At this point, Zai Lab has a negative expected return of -0.0016%. Please make sure to check out Zai Lab's kurtosis, and the relationship between the value at risk and rate of daily change , to decide if Zai Lab performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.36 |
Below average predictability
Zai Lab has below average predictability. Overlapping area represents the amount of predictability between Zai Lab time series from 18th of November 2025 to 2nd of January 2026 and 2nd of January 2026 to 16th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Zai Lab price movement. The serial correlation of 0.36 indicates that just about 36.0% of current Zai Lab price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.36 | |
| Spearman Rank Test | -0.24 | |
| Residual Average | 0.0 | |
| Price Variance | 1.0 |
Net Asset is the value used in calculating NAV of a fund. NAV (or Net Asset Value) is computed once a day based on the formula that uses closing prices of all positions in the fund's portfolio.
| Competition |
Zai Total Assets
Total Assets |
|
Based on the recorded statements, Zai Lab has a Net Asset of 1.19 B. This is much higher than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The net asset for all United States stocks is notably lower than that of the firm.
Zai Net Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Zai Lab's direct or indirect competition against its Net Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Zai Lab could also be used in its relative valuation, which is a method of valuing Zai Lab by comparing valuation metrics of similar companies.Zai Lab is currently under evaluation in net asset category among its peers.
Zai Lab Current Valuation Drivers
We derive many important indicators used in calculating different scores of Zai Lab from analyzing Zai Lab's financial statements. These drivers represent accounts that assess Zai Lab's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Zai Lab's important valuation drivers and their relationship over time.
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 (projected) | ||
| Market Cap | 603.4M | 301.7M | 256.1M | 2.7B | 2.4B | 2.5B | |
| Enterprise Value | (345.2M) | (686.4M) | (518.9M) | 2.4B | 2.1B | 2.2B |
Zai Lab ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Zai Lab's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Zai Lab's managers, analysts, and investors.Environmental | Governance | Social |
Zai Lab Institutional Holders
Institutional Holdings refers to the ownership stake in Zai Lab that is held by large financial organizations, pension funds or endowments. Institutions may hold large blocks of Zai Lab's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Zai Lab's value.| Shares | Mpm Oncology Impact Management Lp | 2025-06-30 | 745.1 K | Jennison Associates Llc | 2025-06-30 | 592.3 K | Cam Group Holding A/s | 2025-06-30 | 510 K | Blackrock Inc | 2025-06-30 | 455.3 K | B Group, Inc | 2025-06-30 | 400 K | Connor Clark & Lunn Inv Mgmt Ltd | 2025-06-30 | 387.4 K | Citadel Advisors Llc | 2025-06-30 | 366.2 K | Xy Capital Ltd | 2025-06-30 | 362.6 K | Morgan Stanley - Brokerage Accounts | 2025-06-30 | 289.1 K | Fmr Inc | 2025-06-30 | 6.2 M | Capital World Investors | 2025-06-30 | 6 M |
Zai Fundamentals
| Return On Equity | -0.29 | ||||
| Return On Asset | -0.13 | ||||
| Profit Margin | (0.47) % | ||||
| Operating Margin | (0.42) % | ||||
| Current Valuation | 1.74 B | ||||
| Shares Outstanding | 112.07 M | ||||
| Shares Owned By Insiders | 1.70 % | ||||
| Shares Owned By Institutions | 32.31 % | ||||
| Number Of Shares Shorted | 3.59 M | ||||
| Price To Book | 2.96 X | ||||
| Price To Sales | 5.08 X | ||||
| Revenue | 398.99 M | ||||
| Gross Profit | 40.55 M | ||||
| EBITDA | (234.57 M) | ||||
| Net Income | (257.1 M) | ||||
| Cash And Equivalents | 1.26 B | ||||
| Cash Per Share | 13.10 X | ||||
| Total Debt | 153.47 M | ||||
| Debt To Equity | 0.02 % | ||||
| Current Ratio | 7.91 X | ||||
| Book Value Per Share | 6.87 X | ||||
| Cash Flow From Operations | (214.87 M) | ||||
| Short Ratio | 4.67 X | ||||
| Earnings Per Share | (1.90) X | ||||
| Price To Earnings To Growth | (0.17) X | ||||
| Target Price | 43.88 | ||||
| Number Of Employees | 1.87 K | ||||
| Beta | 0.89 | ||||
| Market Capitalization | 2.24 B | ||||
| Total Asset | 1.19 B | ||||
| Retained Earnings | (2.45 B) | ||||
| Working Capital | 751.1 M | ||||
| Net Asset | 1.19 B |
About Zai Lab Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Zai Lab's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Zai Lab using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Zai Lab based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Zai Lab offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Zai Lab's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Zai Lab Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Zai Lab Stock:Check out For information on how to trade Zai Stock refer to our How to Trade Zai Stock guide.You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zai Lab. Anticipated expansion of Zai directly elevates investor willingness to pay premium valuations. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Zai Lab assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share (1.90) | Revenue Per Share | Quarterly Revenue Growth 0.135 | Return On Assets | Return On Equity |
The market value of Zai Lab is measured differently than its book value, which is the value of Zai that is recorded on the company's balance sheet. Investors also form their own opinion of Zai Lab's value that differs from its market value or its book value, called intrinsic value, which is Zai Lab's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Zai Lab's market value can be influenced by many factors that don't directly affect Zai Lab's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Zai Lab's value and its price as these two are different measures arrived at by different means. Investors typically determine if Zai Lab is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, Zai Lab's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.